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Directly Observed Treatment - Short course (DOTS) 
has been declared as the global strategy for tuberculosis 
(TB) control by the World Health Organization (WHO) 
since 1991. This strategy has shown to reverse the TB 
epidemic in many countries. Principles of the DOTS 
strategy have had many contributions from research 
carried out in India2-7. 
Scientific studies carried out on the treatment of TB 
in india2 had shown the necessity and feasibility of giving 
drugs under supervision as also efficacy and safety of 
domiciliary treatment7. The evidences based largely on 
the effectiveness of DOTS in industrialized countries are 
indicative of the fact that DOTS would reverse the alarming 
trend in TB incidence throughout the world. It is thus 
evident that TB is amenable to management and cure 
when appropriate resources are provided. 
The theme of the WHO for the World Tuberculosis 
Day (March 24) 2003 centers around ‘people with TB’ 
and the slogan ‘DOTS cured me, it will cure you too’ 
has been adopted to project the cured patient as a living 
proof that TB is curable. A programme manager from a 
district where DOTS has been successfully implemented 
has aptly said, " A cured tuberculosis patient is the 
best pamphlet " for advocacy of DOTS strategy for TB 
The Revised National Tuberculosis Control 
Programme (RNTCP) in India is one of the largest 
programmes in the world and more than 800,000 TB 
patients have been treated under this programme with 
a success rate of more than 80%8. The DOT Providers 
(DPs) are primarily responsible for the success of the 
programme at the field level by giving a VIP status to 
the patient in the programme. This write-up is a reflection 
as to how patients and the DOT providers perceive their 
role in the DOTS programme. 
Success of the RNTCP depends on the successful 
interaction between patients and the DOT providers. 
Because of the stigma attached to the disease it has 
become increasingly important to have a provider 
preferred by the patient. The RNTCP provides an 
opportunity for this through the decentralized approach 
at the governmental health system and even at the 
control. 
This issue commemorates the World Tuberculosis Day (March 24, 2003) 
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community level. For a large proportion of patients, the 
private sector is the first point of contact and the 
programme is making efforts to involve the private sector 
through a public-private mix. In Chennai city, a non- 
government organizatiqn (NGO) 'Advocacy for Control 
of Tuberculosis' is involved with the idea of inducting an 
array of community DPs on a one to one basis. The 
NGO has utilized the services of a variety of DPs from 
organized and unorganized sectors, ranging from 
housewives to other responsible members of the 
community, or other NGOs for the treatment of TB patients. 
Scientists of the Tuberculosis Research Centre 
(TRC), Chennai have interviewed some of the 
tuberculosis patients and DOT providers from the urban 
and rural community where patients are being treated 
with the DOTS strategy. Some of the success stories 
as narrated by patients and DOT providers are 
reproduced here: 
Experience of a patient - A tailor by profession 
In the year 2000, I had cough and fever of 
one month duration. I attended a PHC and was 
told that I have developed TB. The treatment was 
started but could not be continued beyond I month 
as I had severe giddiness and vomiting. I felt better 
after stopping the treatment. My parents also said 
that my diagnosis might have been wrong and did 
not see the need to continue treatment. 
However my cough and fever reappeared after 
about 2 year. Now I consulted a private practitioner 
who took an X-ray and said that I had TB. I was 
again referred to the Government hospital where 
sputum was examined and it was confirmed that 
TB had recurred Doctor scolded me for not having 
completed the treatment on previous occasion itself 
The treatment was started again. This time my 
employer accompanied me to the hospital. He agreed 
to give the medicines under his supervision. Again 
I started getting vomiting and giddiness and was 
not able to work. I continued the treatment and 
attended the hospital as per the instructions of the 
health worker and was ultimately cured and got rid 
of the medicines. I am very thankful to the health 
staff for having motivated me to take the complete 
treatment as a result of which I was cured. I wish 
I had taken the treatment regularly on the previous 
occasion itself 
\ 
Experience of a 30 year old male patient 
I was suffering from cough, fever and 
reduced appetite for the past 2 months. I was 
shattered when I was diagnosed to have TB. The 
Doctor and the health staff informed me about 
the disease and motivated and convinced me for 
regular treatment. 
The treatment was provided at an ICDS Centre 
close to my house. I am thankful to the ICDS 
teacher and other staff for having cured me of 
'TB by DOTS. Now I Know the symptoms of the 
disease and have sent some other villagers who were 
coughing to the PHC where I had treatment. Three 
Patients of them were diagnosed as having TB and 
were started on treatment. I told them to be regular 
for treatment. All the above patients got cured 
of the disease. I am even willing to take the 
responsibility of giving medicines to other patients 
if an opportunity is given to me. 
The above experiences by the patients point to the 
significance of DPs in the success of programme, and 
to the fact that the cured patients themselves are willing 
to help other patients. Drugs are essential for successful 
treatment of patients but still an important aspect that 
motivates the patient to complete the treatment is the 
human bond developed between patients and provider 
during the treatment period due to their frequent 
interactions. 
Having seen the satisfactory experiences of the cured 
patients it is necessary to examine the perspective of 
the DOT Providers from various strata of the community. 
Experience of a community DOT provider 
In a rural area, a caretaker of a cycle stand 
near a railway station was providing DOTfor 
about 7 patients. 
Since those patients had to pass by my 
shop they found it convenient to collect the 
drugs from me. 
I feel so proud to be of use of these patients 
and was happy to see them improving. At the 
moment I am not having any patient to give 
medicines but I am eagerly waiting to continue 
to be a DOT provider. 
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participation of the community in the TB control 
programme that has helped the patients for successfully 
completing their treatment. The attitude of the provider 
helps the patient to complete treatment and get cured. 
Many of the cured patients have expressed their 
willingness and happiness to give medicines for other 
patients in their area to help them also get cured. 
Why Should We Need DOTS? 
It is clear from the above illustrations that despite all 
the criticism and antagonism DOTS have come to stay 
in the control of tuberculosis. 
The key to achieve a high cure rate among TB patients 
is regular and complete treatment in a specified time 
period. TB being a chronic disease and requiring long 
duration of treatment, it has always been a challenge to 
ensure adherence to treatment. 
Adherence to treatment in most diseases requiring 
long-term treatment is inversely proportional to the length 
of treatment9. This holds true in TB management also 
especially where patients are supplied with drugs for 
self-administration. When a patient with pulmonary TB 
feels better there is no compelling reason to continue to 
take medicines2. 
According to Annik Rouillon former Executive Director 
of the International Union Against Tuberculosis and Lung 
Diseases (IUATLD) -to default is the natural reaction of 
normal, sensible people: a person who continues to 
swallow drugs or have injections with complete regularity 
in the absence of encouragement and help from others 
is the abnormal one10. 
As one cannot predict which patients are likely to 
be regular for treatment it becomes mandatory to give 
each and every patient, drugs under direct observation. 
Controlled clinical trials at TRC, Chennai have 
demonstrated that >95 % cure can be achieved if drugs 
are administered under supervision and thus DOT has 
been a major contribution to the DOTS strategy followed 
world-wide. 
Epidemiological evidences suggest that decrease 
in cases results from an interruption in the spread of 
infection because of better rates of completion of treatment 
and expanded use of DOT11. 
This strategy is very patient friendly as the treatment 
is brought as close to the patient as possible. Treatment 
is made convenient to the patient with regard to timing 
of attendance, distance to be travelled, and choice of 
DOT provider. The flexibility to choose the DOT provider 
makes the patient feel more comfortable as far as the 
stigma is concerned. In the RNTCP there is 
decentralization of the treatment services from district 
to sub district level and patient can avail the treatment 
even at the community. Another positive aspect of DOTS 
is its cost effectiveness12,13. 
Who Could be a DOT Provider? 
Generally it is believed that giving the drugs to patients 
is the responsibility of pharmacist or the nursing staff. 
The concept of decentralization is entrusting the 
responsibility of giving medicines to any individual with 
sympathy, care, helping tendency and make the patient 
feel secure. 
In the RNTCP onus of cure is on the health system. 
A good DOTS provider ensures a good programme. There 
is great flexibility in the revised programme of giving the 
patients the right to choose a provider convenient to 
him. Anyone who is acceptable and accessible to the 
These examples give an idea of the successful 
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patient, and accountable to the health system could be 
the DOTS Provider. These factors help to bring the 
treatment closer to the patient so that he is able to 
complete the treatment. More than qualification, it is 
the attitude of the provider towards the patient that 
matters. 
A person will qualify to become a DP if he/she is 
able to undertake the following activities. 
Give drugs to the patients under direct observation. 
Mark the attendance in the treatment card. 
Visit patient and motivate him/her to come back for 
treatment after default. 
Remind the patient for timely sputum examination. 
These activities do not require any high academic 
qualifications. Once the providers have been selected 
they should be given on-the-spot training regarding duties 
of a DP as mentioned earlier. 
Who is a Successful DP? 
A DP is successful if the patient completes the 
treatment in the prescribed period. This requires a DP 
to be vigilant and committed. The highest challenge 
lies in motivating the patient to continue treatment once 
the sense of well-being creeps in after about a month 
or two of commencing the treatment. The DP should 
take immediate action if patient defaults for treatment 
or for follow up sputum examination, and ensure treatment 
completion/cure. 
Linking of DOTS Providers 
Treatment under DOTS requires a system where each 
patient will be administered drugs under observation and 
for that we need a network of DOTS Providers. Regular 
and complete treatment is essential for cure of TB and 
prevention of both relapse and emergence of multi-drug 
resistant tuberculosis (MDR-TB). Direct observation 
ensures right drugs, with right dosage at right interval. 
The government has identified multi-purpose workers 
(MPWs) as DPs. Because of the multiplicity of their 
responsibility there is a need to decentralize their 
responsibility as a DOT provider at the community level. 
Hence it becomes imperative to select DPs from the 
community to make the treatment convenient to the 
patients. Community DOT Providers (CDPs) are not under 
the direct control of the PHI. The government DPs (GDPs) 
are the crucial link between community and the health 
system. A foolproof link needs to be established between 
MPWs and CDPs for effective DOTS. 
Once a CDP has been identified in consultation with 
the patient, he/she will be briefed about their role in the 
management of the patient. After the treatment box is 
handed over to CDP, it is still the responsibility of the 
MPW to visit the CDP at least once a week for supervision 
and updating of the original card kept at the PHC. Based 
on this information, the medical officer will take necessary 
action as and when required. 
Although it is easy to widen the network of CDPs. 
it is very crucial to supervise their work. Good supervision 
is the essence of any successful programme. 
Supervision helps to: 
Motivate the providers and maintain their initial 
enthusiasm . 
Check the correctness of documentation 
Clarify their doubts, if any. 
Provide on-the-spot training when needed. 
The slogan “Dots cured me it will cure you too” 
will be a strong and useful signal emanating from a 
benefactor in the community. Cured patients could be 
used as a powerful tool to provide DOTS as they are the 
satisfied customers and their services might be better 
accepted by the patients as the stigma is likely to be 
less. In any marketing strategy celebrity endorsement 
policy is widely practiced. to promote the product. This 
has been found successful in the management of many 
public health problems. As in DOTS programme a patient 
is considered A VIP projecting them as celebrities who 
have enjoyed the benefits of DOTS will help to build 
confidence in the new patients as well as among the 
community. 
One of the most successful marketing policies by 
marketing giants is the ‘satisfied costumer approach’. 
A cured patient can be a good advocate and a good 
DOT provider as he has gone through the whole routine 
and he can share his experiences with new patients. He 
can be a good health educator to the patient. Stigma, 
long duration of treatment, etc. are major barriers in the 
treatment of TB from patients point of view. A successfully 
treated patient has experienced these barriers and 
conquered the stigma and inconvenience of daily visits. 
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Their involvement in the DOTS programme will give 
enormous confidence to new patients. 
Despite all the advances in the treatment of TB and 
in-depth knowledge of genomics of the organism, we 
are far away from control of the disease. The renewed 
political commitment and other important strategies like 
diagnosis mainly by sputum microscopy, decentralization 
of treatment services, training and good documentation 
and most importantly, DOT, have started showing good 
results. It is the l0th anniversary of the DOTS strategy 
implementation and approximately 10 million patients 
have been successfully treated world-wide. Every cured 
patient will reduce the number of people getting infected 
every year, people dying of TB, an avoidable death. Jacob 
Kumaresan, former Executive Secretary of Stop TB 
Partnership has aptly said “By now we should be starting 
to turn the tide against TB. After all we have tools so let 
us finish the job”. 
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